digital weight loss company Noom The company's commercial business, Noom for Work, will partner with Liviniti, a national pharmacy benefits manager, to provide plan sponsors and their employees with a digital GLP-1 companion for chronic weight conditions. Announced.
GLP-1, or glucagon-like peptide-1 receptor agonists, are a class of drugs used to treat type 2 diabetes and, more recently, to manage chronic weight conditions.
Noom's GLP-1 Companion integrates with PBM processes to provide nutrition coaching and fitness-focused lessons.
Its digital front door and clinical triage help identify members whose weight impacts their health and best allocate resources to those at highest risk.
Members who sign up with Noom will receive a customized GLP-1 companion program after they indicate they are taking GLP-1 during onboarding. You'll also have access to protein tracking tools, customized interactive mini-courses, and fitness-focused lessons and videos for people of all activity levels.
You can also set goals for successful GLP-1 weight loss within clinically relevant ranges as you progress through your weight loss journey.
“By enhancing all weight loss and obesity care programs with our GLP-1 companion, anyone taking GLP-1 can improve their lifestyle, nutrition, exercise, and coaching for improvement. „They will have access to a customized, integrated program that helps them build lasting habits,“ says Dr. Linda Anegawa, Noom's medical director, in a statement. .
bigger trends
Medical personnel pointed out the following: Rise of GLP-1 drugs Treating chronic weight problems as part of treatment major developments Last year in the healthcare field.
During October Noom announced The company has expanded its digital enterprise product, Noom for Work, to include clinical obesity management solution Noom Med. This will give individuals access to clinicians trained in obesity care who will provide a customized weight loss plan and support for the patient to reduce her dependence on GLP. -1 medicine.
In 2021, Noom scored incredible points $540 million in Series F funding 2021 and $58 million Exactly 2 years ago.
However, digital weight loss companies were not spared widespread impact. Staff reduction Announced within digital health companies in 2022 fired twice That year.
In 2023, the company announced: Third round of personnel reductionswill reportedly lay off about a quarter of its coaches.
Noom has made a number of executive moves and appointments over the past year.
In July, the company announced that CEO and co-founder Saeju Jeong would step down after 16 years, but would continue to serve as chairman of the board.jeff cook was appointed He has been sworn in as the new CEO and member of the Board of Directors.
Noom last month announced the appointment Appointment of new Chief Financial Officer, General Counsel, and Chief Technology Officer.